Sacramento, CALIFORNIA4 Active Studies

Diabetic Retinopathy Clinical Trials in Sacramento, CALIFORNIA

Find 4 actively recruiting diabetic retinopathy clinical trials in Sacramento, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
2,244
Enrolling

Recruiting Diabetic Retinopathy Studies in Sacramento

RecruitingSacramento, CALIFORNIANCT06957080

A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of EYE103 in comparison with the active control, ranibizumab, in patients with diabetic ma...

960 participants
EyeBiotech Ltd.
View Study Details
RecruitingSacramento, CALIFORNIANCT04661358

Fenofibrate for Prevention of DR Worsening

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately s...

560 participants
Jaeb Center for Health Research
View Study Details
RecruitingSacramento, CALIFORNIANCT06850922

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema

This study aims to evaluate the ocular and systemic safety, tolerability and efficacy of RO7446603 in participants with diabetic macular edema (DME). The study consists of 2 segments: Phase I (Parts 1...

546 participants
Genentech, Inc.
View Study Details
RecruitingSacramento, CALIFORNIANCT06321302

A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study. The purpose of this study is to find ou...

178 participants
Boehringer Ingelheim
View Study Details

About Diabetic Retinopathy Clinical Trials in Sacramento

Diabetic retinopathy is a diabetes complication that affects the blood vessels in the retina and is the leading cause of blindness in working-age adults. Diabetic macular edema (DME) involves fluid accumulation in the macula. Treatment includes anti-VEGF injections, laser therapy, and blood sugar control.

There are currently 4 diabetic retinopathy clinical trials recruiting participants in Sacramento, CALIFORNIA. These studies are seeking a combined 2,244 participants. Research is being sponsored by EyeBiotech Ltd., Jaeb Center for Health Research, Genentech, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Diabetic Retinopathy Clinical Trials in Sacramento — FAQ

Are there diabetic retinopathy clinical trials in Sacramento?

Yes, there are 4 diabetic retinopathy clinical trials currently recruiting in Sacramento, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What diabetic retinopathy treatments are being tested?

The 4 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for diabetic retinopathy.

Data updated March 2, 2026 from ClinicalTrials.gov